Susanne AlbanView profile
Professor
Prof. Dr. Susanne Alban leads the Kiel Pharmacognosy Group (KPG) at Christian-Albrechts-University Kiel, focusing on glycans and glycobiology with applications in inflammation, metastasis, and cancer. Her research bridges pharmacognosy and hemostasis , developing novel anticoagulant and anti-inflammatory agents from marine and plant sources. Academic Affiliation : Christian-Albrechts-University Kiel Key Collaborations : European Union's EFF project, pharmaceutical industry, and medical researchers Research Interests : Structure-function relationships of sulfated glycans Antimetastatic and anti-inflammatory mechanisms Development of heparin alternatives with reduced bleeding risk Pharmaceutical quality control for sulfated polysaccharides Article Trends : Recent publications emphasize marine biotechnology (Fucus vesiculosus, Saccharina latissima), structure-activity analysis of sulfated polysaccharides, and clinical anticoagulant challenges (e.g., 2008 heparin contamination). Keywords reveal focus on inflammation-metastasis-hemostasis interplay , fluorescence assay development , and complement/contact system modulation . Patents & Methodologies : Novel heparin quality control assays (PCT/DE 2009/001215) Laminarin sulfate-based anti-inflammatory drugs (WO 0236132-A1) Fluorescence microplate assays for sulfated glycans Complement-inhibiting glucan sulfates Education & Mentorship : Supervised multiple doctoral and diploma theses on sulfated glycan mechanisms, including studies by Ann-Kathrin Schoenfeld (2017) and Niels Grünewald (2009). Her habilitation (1999) at University of Regensburg established her career in carbohydrate-based drug development. Applied Projects : Coordinated interdisciplinary research on Baltic Sea macrophytes (EFF-funded 'Riff Nienhagen'), analyzing sulfated polysaccharides from Delesseria sanguinea for pharmaceutical applications. Developed standardized extraction methods for reproducible bioactive compounds.





